Skip to main content
SpringerLink
Log in

Intravenous Therapies for Intractable Headache

  • Chapter
  • First Online:
Interventional Management of Head and Face Pain

  • 1797 Accesses

Abstract

Unrelenting, severe headaches are difficult to treat since they usually do not respond to conventional medical management. Among invasive interventions, infusion therapies have emerged as an effective treatment for refractory headaches when other noninvasive treatments have been exhausted. This chapter reviews several pharmacological options of intravenous infusions for intractable headaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008;7:354–61.

    Article  PubMed  Google Scholar 

  2. Epidemiology of headache. http://www.iasppain.org/AM/Template.cfm?Section=Fact_Sheets4&Template=/CM/ContentDisplay.cfm&ContentID=14452.

  3. Olsen J. The international classification of headache disorders. Headache. 2008;48:691–3.

    Article  Google Scholar 

  4. American Headache Society. Refractory headache special section, meeting minutes. 2006. Available from: http://www.americanheadachesociety.org/assets/1/7/Refractory_Headache_Section_Minutes_6-23-06.pdf. 23 June 2006.

  5. Silberstein SD, Dodick DW, Pearlman S. Defining the pharmacologically intractable headache for clinical trials and clinical practice. Headache. 2010;50:1499–506.

    Article  PubMed  Google Scholar 

  6. Tfelt-Hansen PC, Koehler PJ. One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010. Headache. 2011;51:752–78.

    Article  PubMed  Google Scholar 

  7. Lambert GA. The lack of peripheral pathology in migraine headache. Headache. 2010;50:895–908.

    Article  PubMed  Google Scholar 

  8. Stillman MJ. Medical treatment of chronic daily headaches: chronic migraine, chronic tension-type headaches, new daily persistent headaches, hemicrania continua, and medication overuse headache. In: Tepper SJ, Tepper DE, editors. The Cleveland clinic manual of headache therapy. New York: Springer Science; 2011. p. 167–81.

    Chapter  Google Scholar 

  9. Sarchielli P, Di Filippo M, Nardi K, Calabresi P. Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep. 2007;11:343–51.

    Article  PubMed  Google Scholar 

  10. Kelley NE, Tepper DE. Rescue therapy for acute migraine, Part 1: triptans, dihydroergotamine, and magnesium. Headache. 2012;52:114–28.

    Article  PubMed  Google Scholar 

  11. Charles JA, von Dohln P. Outpatient home-based continuous intravenous dihydroergotamine therapy for intractable migraine. Headache. 2010;50:852–60.

    Article  PubMed  Google Scholar 

  12. Gelfand AA, Goadsby PJ. A neurologist’s guide to acute migraine therapy in the emergency room. Neurohospitalist. 2012;2:51–9.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 1986;36:995–7.

    Article  CAS  PubMed  Google Scholar 

  14. Silberstein SD, Elliott A, et al. Repetitive intravenous DHE in the treatment of refractory headache. Headache. 1990;30:334–9.

    Article  CAS  PubMed  Google Scholar 

  15. Ford RG, Ford KT. Continuous intravenous dihydroergotamine in the treatment of intractable headache. Headache. 1997;37:129–36.

    Article  CAS  PubMed  Google Scholar 

  16. Linder SL. Treatment of childhood headache with dihydroergotamine mesylate. Headache. 1994;34:578–80.

    Article  CAS  PubMed  Google Scholar 

  17. Kabouche MA, Qureshi FA, Lewis DW. Headache in the pediatric emergency department. Headache in Children and Adolescents. BC Decker Inc. 2008;49:106–9.

    Google Scholar 

  18. Stillman MH, Zajac D, Rybicki LA. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience. Headache. 2004;44:65–9.

    Article  PubMed  Google Scholar 

  19. Krusz JC. Intravenous treatment of chronic daily headaches in the outpatient headache clinic. Curr Pain Headache Rep. 2006;10:47–53.

    Article  PubMed  Google Scholar 

  20. Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate vs intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001;41:976–80.

    Article  CAS  PubMed  Google Scholar 

  21. Shahien R, Saleh SA, Bowirrat A. Intravenous sodium valproate aborts migraine headaches rapidly. Acta Neurol Scand. 2011;123:257–65.

    Article  CAS  PubMed  Google Scholar 

  22. Cutrer FM, Moskowitz MA. The actions of valproate and neurosteroids in a model of trigeminal pain. Headache. 1996;36:265.

    Article  Google Scholar 

  23. Schwartz TH, Karpitskiy VV, Sohn RS. Intravenous valproate sodium in the treatment of daily headache. Headache. 2002;42:519–22.

    Article  PubMed  Google Scholar 

  24. Mauskop A, Varughese J. Why all migraine patients should be treated with magnesium. J Neural Transm. 2012;119:575–9.

    Article  CAS  PubMed  Google Scholar 

  25. Wang F, Van Den Eeden SK, Ackerson LM, et al. Oral magnesium oxide prophylaxis of frequent migraine headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003;43:601–10.

    Article  PubMed  Google Scholar 

  26. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache. 1996;36:154–60.

    Article  CAS  PubMed  Google Scholar 

  27. Demirkaya S, Vural O, Dora B, Topcuoglu MA. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache. 2001;41:171–7.

    Article  CAS  PubMed  Google Scholar 

  28. Mays MA. Treatment of major secondary headaches. In: Tepper SJ, Tepper DE, editors. The Cleveland clinic manual of headache therapy. New York: Springer Science; 2011. p. 195–208.

    Chapter  Google Scholar 

  29. Simmonds MK, Rashiq S, Sobolev IA, Dick BD, Gray DP, Stewart BJ, Jamieson-Lega KI. The effect of single-dose propofol injection on pain and quality of life in chronic daily headache: a randomized, double-blind, controlled trial. Anesth Analg. 2009;109:1972–80.

    Article  CAS  PubMed  Google Scholar 

  30. Krusz JC, Scott V, Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache. 2000;40:224–30.

    Article  CAS  PubMed  Google Scholar 

  31. Mendes PM, Silberstein SD, Young WB, Rozen TD, Paolone MF. Intravenous propofol in the treatment of refractory headache. Headache. 2002;42:638–41.

    Article  PubMed  Google Scholar 

  32. Marmura M, Rosen N, Abbas M, Silberstein S. Intravenous lidocaine in the treatment of refractory headache: a retrospective case series. Headache. 2009;49:286–91.

    Article  PubMed  Google Scholar 

  33. Stillman MJ. Treatment of trigeminal autonomic cephalalgias and other primary headaches. In: Tepper SJ, Tepper DE, editors. The Cleveland clinic manual of headache therapy. New York: Springer Science; 2011. p. 137–50.

    Chapter  Google Scholar 

  34. Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia. 2003;23:963–71.

    Article  CAS  PubMed  Google Scholar 

  35. Marmura MJ. Intravenous lidocaine and mexiletine in the management of trigeminal autonomic cephalalgias. Curr Pain Headache Rep. 2010;14:145–50.

    Article  PubMed  Google Scholar 

  36. Fanaee E, Anitescu M, Patil SK. Sustained pain relief after lidocaine infusions for chronic pain syndromes: a retrospective analysis. ASA. 2010;A301. http://education.asahq.org/sites/production.asahq-dev.org/files/a301.pdf.

  37. Patil SK, Anitescu M. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5 year retrospective analysis. Pain Med. 2012;13:263–9.

    Article  PubMed  Google Scholar 

  38. Flexman AM, Ng JL, Gelb AW. Acute and chronic pain following craniotomy. Curr Opin Anaesthesiol. 2010;23:551–7.

    Article  PubMed  Google Scholar 

  39. Bar-Joseph G, Guilburd Y, Tamir A, Guilburd JN. Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension. J Neurosurg Pediatr. 2009;4:40–8.

    Article  PubMed  Google Scholar 

  40. Schwedt TJ, Silberstein SD. 14th international headache congress: clinical highlights. Headache: the Journal of Head and Face Pain. 2010;50(3):509–19.

    Google Scholar 

  41. Krusz JC, Cagle J, Scott-Krusz VB. Ketamine for treating multiple types of headaches (abstract). Cephalalgia. 2009;29 Suppl 1:151–2.

    Google Scholar 

  42. Vinson DR. Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med. 2002;39:215–22.

    Article  PubMed  Google Scholar 

  43. Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines and others. Headache. 2012;52:292–306.

    Article  PubMed  Google Scholar 

  44. Kriegler JS. Acute treatment of episodic migraine. In: Tepper SJ, Tepper DE, editors. The Cleveland clinic manual of headache therapy. New York: Springer Science; 2011. p. 107–19.

    Chapter  Google Scholar 

  45. Gilmore B, Michael M. Treatment of acute migraine headache. Am Fam Physician. 2011;83:271–80.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesia and Critical Care, University of Chicago Medical Center, 5841 S. Maryland Ave, MC 4028, Chicago, IL, 60637, USA

    Magdalena Anitescu MD, PhD

Authors
  1. Magdalena Anitescu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Magdalena Anitescu MD, PhD .

Editor information

Editors and Affiliations

  1. Center for Pain Medicine, Western Reserve Hospital, Cuyahoga Falls, Ohio, USA

    Samer N. Narouze

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Anitescu, M. (2014). Intravenous Therapies for Intractable Headache. In: N. Narouze, S. (eds) Interventional Management of Head and Face Pain. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8951-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8951-1_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8950-4

  • Online ISBN: 978-1-4614-8951-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation